Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
HotStart Universal 2X FAST Green qPCR Master Mix: Mechanism
2026-05-20
HotStart Universal 2X FAST Green qPCR Master Mix offers rapid and specific PCR amplification, even in the presence of common blood inhibitors. The master mix employs a mutant hot-start Taq polymerase and Green I dye for real-time monitoring and robust gene expression analysis. Its ROX reference dye ensures compatibility with all major qPCR platforms.
-
Harnessing Z-VAD-FMK: Strategic Caspase Modulation for Trans
2026-05-20
This thought-leadership article explores the mechanistic nuances and translational opportunities enabled by Z-VAD-FMK, a leading pan-caspase inhibitor from APExBIO. By integrating the latest findings on caspase-3-mediated IL-18 processing and their implications for immune cell mobilization and cancer therapy, we provide actionable guidance for researchers seeking to advance apoptosis pathway studies and translational innovation.
-
Drosophila Keap1 Nuclear Condensates in Oxidative Stress Res
2026-05-19
This study uncovers how the Drosophila Keap1 protein forms nuclear condensates in response to oxidative stress, revealing a new mechanism for Keap1's role beyond cytoplasmic regulation of Nrf2. These findings deepen our understanding of phase separation in transcriptional control and suggest broader implications for stress adaptation and developmental regulation.
-
ac4C Modification of lncRNA Gm26917 Regulates FGSC Translati
2026-05-19
This study uncovers a pivotal role for N4-acetylcytidine (ac4C) modification on the lncRNA Gm26917 in promoting ribosomal protein mRNA recruitment and translation efficiency in female germline stem cells (FGSCs). Through integrated sequencing and molecular approaches, the research elucidates an ac4C-Gm26917–EEF1A1–RPL10 axis essential for FGSC maintenance, revealing novel regulatory layers in stem cell fate and translational control.
-
Branched Endosomal Disruptor Lipids Advance mRNA Delivery Ef
2026-05-18
This study introduces a novel class of branched ionizable lipids (BEND lipids) that significantly enhance lipid nanoparticle-mediated delivery of mRNA and CRISPR-Cas9 complexes. The findings demonstrate improved endosomal escape, hepatic gene editing, and T cell transfection, addressing key barriers in mRNA therapeutic development.
-
Cy7 NHS Ester: Practical Guide for Near-Infrared Protein Lab
2026-05-18
Cy7 NHS ester is a sulfonated, water-soluble near-infrared dye for bioimaging, specifically designed for efficient labeling of amino groups in proteins and peptides without denaturation risk. It is ideal for live-cell and in vivo fluorescent imaging, but not recommended where long-term dye solutions or organic solvent-based protocols are required.
-
Vorinostat in Translational Oncology: Mechanism, Impact, Vis
2026-05-17
This thought-leadership article investigates Vorinostat (SAHA, MK0683) as an HDAC inhibitor, integrating mechanistic insights on epigenetic modulation and recent discoveries in apoptosis signaling. It bridges foundational biology with strategic guidance for translational researchers, situates Vorinostat within the evolving competitive landscape, and offers a forward-looking outlook grounded in newly cited mechanistic evidence.
-
EPZ5676: Transforming DOT1L Inhibition from Leukemia to Fibr
2026-05-16
This article bridges mechanistic insights and translational strategy, exploring how EPZ5676—a highly selective DOT1L inhibitor—drives innovation in both MLL-rearranged leukemia research and emerging fibrotic disease applications. By weaving together new evidence, best-in-class protocols, and a competitive landscape analysis, we chart a path for researchers to advance from cellular assays to disease models with confidence.
-
AM 281 (B6603): Reliable CB1 Antagonist for Neuropharmacolog
2026-05-15
This article offers a scenario-driven, evidence-based exploration of AM 281 (SKU B6603), a highly selective CB1 cannabinoid receptor antagonist, as a solution for challenges in neuropharmacology assays. Designed for biomedical researchers and lab technicians, it details best practices for experimental setup, protocol optimization, and product selection, with actionable links and protocol parameters. Reference data and vendor comparisons highlight why AM 281 from APExBIO stands out for reproducibility and workflow compatibility.
-
FITC-Concanavalin A (ConA) Conjugate: Technical Use and Prot
2026-05-15
FITC-Concanavalin A (ConA) Conjugate provides a reliable approach for detecting α-D-glucose and α-D-mannose residues on cell surfaces using fluorescence-based assays. This reagent is intended for immunofluorescence staining, flow cytometry, and glycobiology research. It should not be applied to non-carbohydrate binding workflows or used outside its defined storage and stability parameters.
-
2X HyperFusion High-Fidelity Master Mix: Precision for Cloni
2026-05-14
2X HyperFusion High-Fidelity Master Mix delivers unmatched accuracy and efficiency for cloning and gene editing workflows, thanks to its advanced fusion polymerase and rapid cycling capability. Seamlessly integrate high-fidelity PCR into immunotherapy and CRISPR protocols, minimizing errors and maximizing downstream success.
-
Anti-Inflammatory, Anti-Angiogenic Stent Suppresses TISR
2026-05-14
Zhao et al. developed an airway stent that integrates anti-inflammatory and anti-angiogenic strategies to effectively suppress tracheal in-stent restenosis in a rabbit model. By combining anlotinib hydrochloride and silver nanoparticles, the study provides mechanistic and transcriptomic evidence for multi-faceted suppression of fibrosis, angiogenesis, and infection, suggesting a promising translational direction for airway intervention.
-
Hesperadin: Precision Aurora B Kinase Inhibitor for Mitosis
2026-05-13
Hesperadin is a potent Aurora B kinase inhibitor that disrupts mitotic progression by targeting the kinase’s ATP-binding pocket. It is highly effective in inhibiting chromosome alignment and segregation in cell cycle research, with precise IC50 values validated in vitro and in cellular assays. APExBIO supplies this compound for advanced studies on mitotic regulation and cancer.
-
Amitriptyline HCl (B2231): Technical Guidance for Lab Use
2026-05-13
Amitriptyline HCl (SKU B2231) provides researchers with a high-purity, well-characterized agent for rigorous study of neurotransmitter receptor modulation, specifically targeting serotonin, norepinephrine, and related pathways. This compound is optimal for neuropharmacology, cell-based, and signal transduction assays, but should not be used outside the validated applications described in the product specification.
-
Erastin: Precision Ferroptosis Inducer for Cancer Research
2026-05-12
Erastin is the gold-standard ferroptosis inducer, enabling selective, iron-dependent cell death assays in RAS/BRAF-mutant tumor models. This article delivers a bench-to-publication blueprint for robust ferroptosis workflows, protocol optimization, and troubleshooting, grounded in the latest redox signaling research.